share_log

華領醫藥-B：董事名單與其角色和職能

HUA MEDICINE-B: LIST OF DIRECTORS AND THEIR ROLES AND FUNCTIONS

香港交易所 ·  Dec 29, 2023 03:40
Summary by Moomoo AI
華領醫藥-B（股份代號：2552）於2024年1月1日對外公布了其董事會成員名單及各自的角色和職能。董事會成員包括執行董事陳力先生、林潔誠先生和張怡女士；非執行董事Robert Taylor NELSEN先生和Fangxin LI先生；以及獨立非執行董事William Robert KELLER先生、徐耀華先生和張耀樑先生。公司亦公布了董事會下設的四個委員會，包括審核委員會、薪酬委員會、提名委員會和戰略委員會，並詳細列出各董事在委員會中的職位，其中包括委員會主席（標記為C）和委員會成員（標記為M）。這次董事會成員的公布，展示了華領醫藥對公司治理結構的透明度和對專業管理團隊的承諾。
華領醫藥-B（股份代號：2552）於2024年1月1日對外公布了其董事會成員名單及各自的角色和職能。董事會成員包括執行董事陳力先生、林潔誠先生和張怡女士；非執行董事Robert Taylor NELSEN先生和Fangxin LI先生；以及獨立非執行董事William Robert KELLER先生、徐耀華先生和張耀樑先生。公司亦公布了董事會下設的四個委員會，包括審核委員會、薪酬委員會、提名委員會和戰略委員會，並詳細列出各董事在委員會中的職位，其中包括委員會主席（標記為C）和委員會成員（標記為M）。這次董事會成員的公布，展示了華領醫藥對公司治理結構的透明度和對專業管理團隊的承諾。
Hualien Pharmaceutical-B (Stock Code: 2552) announced externally on 1 January 2024 the list of its Board members and their respective roles and functions. The members of the Board of Directors include Executive Directors Mr. Chen Li, Mr. Lin Jie Shing and Ms. Zhang Yi; Non-Executive Directors Mr. Robert Taylor NELSEN and Mr. Fangxin LI; and Independent Non-Executive Directors Mr. William Robert KELLER, Mr. Xu Yiu Wah and Mr. Zhang Yiu Liang. THE COMPANY ALSO ANNOUNCED THE FOUR COMMITTEES THE BOARD HAS APPOINTED, INCLUDING THE AUDIT COMMITTEE, THE REMUNERATION COMMITTEE, THE NOMINATING COMMITTEE AND THE STRATEGY COMMITTEE, AND A DETAILED LISTING OF THE POSITIONS OF THE DIRECTORS ON THE COMMITTEE, WHICH INCLUDES THE CHAIRMAN OF THE COMMITTEE (MARKED AS C) AND THE COMMITTEE MEMBERS (MARKED AS M). This announcement by the Board members demonstrates the transparency of the company's governance structure and commitment to its professional management team.
Hualien Pharmaceutical-B (Stock Code: 2552) announced externally on 1 January 2024 the list of its Board members and their respective roles and functions. The members of the Board of Directors include Executive Directors Mr. Chen Li, Mr. Lin Jie Shing and Ms. Zhang Yi; Non-Executive Directors Mr. Robert Taylor NELSEN and Mr. Fangxin LI; and Independent Non-Executive Directors Mr. William Robert KELLER, Mr. Xu Yiu Wah and Mr. Zhang Yiu Liang. THE COMPANY ALSO ANNOUNCED THE FOUR COMMITTEES THE BOARD HAS APPOINTED, INCLUDING THE AUDIT COMMITTEE, THE REMUNERATION COMMITTEE, THE NOMINATING COMMITTEE AND THE STRATEGY COMMITTEE, AND A DETAILED LISTING OF THE POSITIONS OF THE DIRECTORS ON THE COMMITTEE, WHICH INCLUDES THE CHAIRMAN OF THE COMMITTEE (MARKED AS C) AND THE COMMITTEE MEMBERS (MARKED AS M). This announcement by the Board members demonstrates the transparency of the company's governance structure and commitment to its professional management team.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more